Mountain Crest Acquisition Corp. V
Status: Live Deal
U=S+R
R=S/10
IPO Proceeds, $M | $69.00M |
---|---|
IPO Date | Nov 12, 2021 |
CEO | Suying Liu |
Left Lead | Chardan |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 12 + 3 + 3 + 6 + 12 |
IPO Sector |
General
North America and Asia Pacific regions (excluding China, Hong Kong and Macau) |
IPO Geography | Global |
Target Company | CUBEBIO |
Deal Announced | Aug 29, 2024 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | Asia |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Nov 8, 2024 |
MCAG
MCAGU
MCAGR
Price | $11.20 |
---|---|
Last closing price | $11.24 |
H/L, today | $11.17 / $11.24 |
H/L, 52-week | $9.90 / $11.40 |
Volume, today | 11,643 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Mountain Crest Acquisition Corp. V:
- Structure and cap table
- 4 directors & officers
- 40 filings and events
- 1 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Suying Liu | 33 | Chairman, Chief Executive Officer, and Chief Financial Officer |
Nelson Haight | 56 | Director |
Todd Milbourn | 52 | Director |
Wenhua Zhang | 51 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Chardan | BR | 6,000,000 | units |
6,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.